companydata.dkcompanydata.dk

Biologik ApS: Financial statements 2025

CVR: 36070498

Source: annual report 2025, Danish Business Authority

01/07/202430/06/2025

Biologik ApS (CVR 36070498) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. That is a decrease of 3.6% compared with the year before. Equity in the 2025 report amounted to DKK 408,578. The solvency ratio was 73.9%. The company had 1 employee in the financial year.

Gross Profit
DKK 385,601
Profit/Loss
DKK 234,499
Equity
DKK 408,578
Total Assets
DKK 552,971
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-386 t.234 t.409 t.1
2024-400 t.-35 t.235 t.1
2023-653 t.119 t.329 t.1
2022-258 t.-89 t.268 t.1
2021-593 t.215 t.414 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Biologik ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Biologik ApS appoints new auditorOct 14, 2025

As of October 14, 2025, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Biologik ApS.

Auditor steps down at Biologik ApSOct 14, 2025

As of October 14, 2025, Kreston CM Statsautoriseret Revisions interessentskab has stepped down as auditor of Biologik ApS.

About Biologik ApS

Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity in the 2025 report amounted to DKK 408,578.

Source: annual report 2025, Danish Business Authority